Navigation Links
Male cancer survivor offspring slightly higher risk of congenital birth abnormalities

The incidence of major congenital birth abnormalities was slightly higher in the offspring of male cancer survivors compared with children of fathers with no history of cancer, according to a study published online February 8th in the Journal of the National Cancer Institute.

The increasing number of male cancer survivors has given rise to concerns about the health of their offspring. Although previous studies on children conceived naturally have been reassuring about the health of the children, very few studies have looked at results among children conceived through assisted reproductive technologies (ARTs) such as in vitro fertilization or intracytoplasmatic sperm injection.

To determine the effects of paternal cancer and ARTs on pregnancy outcomes, O. Sthl, M.D., Ph.D., of Lund University Hospital in Sweden, and colleagues, did a cohort study of children born in Sweden and Denmark between 1994 and 2004. Using the Danish Civil Registration System, the Swedish Total Population Register and the Swedish Multigenerational Register, and the Danish and Swedish cancer registries, the researchers identified 8670 children with a paternal history of cancer, 8162 of whom were conceived naturally and 508 through ARTs.

The researchers found that a paternal history of cancer was associated with a 17% increased relative risk of major congenital malformations (however, the absolute risk was only 3.7% compared to 3.2% for offspring of males without any history of cancer), regardless of mode of conception. Indeed, the researchers found that the usage of assisted reproductive technologies for conception did not cause any statistically significant increase in the risk of malformations among offspring compared to natural conception.

The researchers write: "We observed a statistically significant but modest increase in the risk of major congenital abnormalities among offspring of males with a history of cancer, independent of the mode of conception."

Although the researchers were unable to examine the effect of specific treatments, they conducted sub-analyses of cancers that receive similar treatments. For example, whereas hematological malignancies, generally treated with chemotherapy, were associated with a non-statistically significant increased risk of congenital abnormalities in children with paternal history of cancer compared to those without, no such increased risk was seen with children with a paternal history of testicular seminoma, which is generally treated with radiotherapy.

In an accompanying editorial, Lisa B. Signorello, ScD, of the International Epidemiology Institute and Vanderbilt University, and colleagues, write that the study findings are "overall quite reassuring," but incomplete, because of limited treatment data for cancer survivors and the fact that it was restricted to male cancer survivors. The authors also point out that a possible link, as interpreted by the authors, between paternal history of cancer and congenital abnormalities in offspring "defies nearly all relevant epidemiological evidence to date."

Furthermore, they write that possible explanations of the slightly elevated rate of congenital abnormalities among male offspring in Denmark and Sweden is heightened surveillance in children whose parents have had serious, sometimes inherited disease.

Although most evidence goes against the probability that cancer treatment is associated with genetic damage in offspring, the authors write, it is still an important issue to study, especially as patients undergo DNA-damaging treatments that interfere with molecular processes. "We still do not know how sensitive or tolerant the human germ cell is to these mutagenic insults," the authors write.


Contact: Kristine Crane
Journal of the National Cancer Institute

Related medicine news :

1. Enhancing arrest of cell growth to treat cancer in mice
2. Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer
3. The National Coalition for Cancer Survivorship Joins the Commission on Cancer
4. Low forms of cyclin E reduce breast cancer drugs effectiveness
5. Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
6. Soft drinks may increase risk of pancreatic cancer
7. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
8. Genes Play Role in Prognosis With Non-Small Cell Lung Cancers
9. Single gene mutation induces endometrial cancer
10. Certain genetic profiles associated with recurrence-free survival for non-small cell lung cancer
11. Molecular pathways linked to sex, age affect outcomes in lung cancer
Post Your Comments:
(Date:11/29/2015)... ... 29, 2015 , ... Effective immediately, every single IguanaMed scrub style will be ... Target is offering a “Buy One Scrub Set, Get the 2nd Scrub Set 50% ... IguanaMed at a discounted price. , IguanaMed’s mission is to outfit every ...
(Date:11/28/2015)... ... November 28, 2015 , ... Safe storage for contraceptive devices may not ... from Lakewood, New Jersey and the other from Bradley Beach, New Jersey, there is ... the expense of having to replace NuvaRings more often than necessary. As such, it ...
(Date:11/28/2015)... CA (PRWEB) , ... November 28, 2015 , ... Pixel ... fully customizable media panels to choose from, the possibilities are endless. Users have full ... more. With the ProPanel: Pulse masking effects, users are sure to get heads to ...
(Date:11/27/2015)... Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... study carried out by the University of Toronto and the University of British Columbia ... of hospitalizations for head injuries. The article explains that part of the reason for ...
(Date:11/27/2015)... ... ... A team of Swiss doctors has released a report on mesothelioma relapse ... the findings on the website. Click here to read the details now. ... who were treated with chemotherapy followed by EPP surgery. Among the 106 patients who ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 25, 2015  The American Academy of Pediatrics ... and the March of Dimes cheered today,s signature ... Infants Act of 2015 (S.799), which takes ... born exposed to drugs, such as opioids, and ... all three organizations have worked together leading advocacy ...
(Date:11/25/2015)... 25, 2015 On Tuesday, November 24, ... trial against Wright Medical Technology, Inc. for product ... metal-on-metal hip implant device, awarded $11 million in ... week trial and three days of deliberations, the ... was defectively designed and unreasonably dangerous, and that ...
(Date:11/25/2015)... TEL AVIV, Israel , November 25, 2015 /PRNewswire/ ... Ltd. (NASDAQ: KTOV ) (TASE: KTOV), a biopharmaceutical ... the simultaneous treatment of various clinical conditions, today announced ... of 3,158,900 American Depository Shares ( ADSs ), each ... to purchase up to 3,158,900 ADSs. The ADSs and ...
Breaking Medicine Technology: